Dr. David J. Kwiatkowski
California Institute of Technology, Pasadena, CA
Columbia University College of Physicians & Surgeons, New York, NY - 1979
Massachusetts General Hospital, Boston, MA – 1982
Massachusetts General Hospital, Boston, MA – 1984
Dr. David J. Kwiatkowski is a thoracic oncology specialist who serves as senior physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute (BWH/DFCI). He also holds an academic post of professor of medicine at Harvard Medical School. Prior to joining the staff at BWH/DFCI in 1991, Dr. Kwiatkowski was employed by Massachusetts General Hospital (MGH).
Dr. Kwiatkowski received his BSc from the California Institute of Technology in Pasadena, California and his PhD from the Massachusetts Institute of Technology (MIT) located in Cambridge, Massachusetts (both degrees in mathematics). He then went on to pursue his medical degree at Columbia University College of Physicians & Surgeons in New York, New York where he graduated in 1979 with the esteemed Janeway Prize which recognizes the highest achievement and abilities in the medical class. An internship and residency ensued at the MGH in Boston where Dr. Kwiatkowski’s training was concentrated on internal medicine and hematology-oncology.
Clinical and Laboratory Research
A thoracic oncology specialist, Dr. Kwiatkowski’s clinical focus is on thoracic malignancies, among them thymic cancer, lung cancer, and mesothelioma. He is board-certified in both internal medicine and medical oncology.
He has a much deeper familiarity with mesothelioma than the average thoracic oncologist, and sees many patients on referral from around the country.
Dana-Farber Cancer Institute Physician Profile
A self-taught human and cancer geneticist, Dr. Kwiatkowski’s research interests revolve around individualized and targeted therapies for cancers based on their mutations. He is particularly interested in mesothelioma treatment strategies and is actively involved on several fronts in developing clinical trials and novel approaches to therapy for this rare malignancy.
Since 2007, Dr. Kwiatkowski has led the Dana-Farber/Harvard Cancer Center Cancer Genetics program. He also serves as an associate member of the Broad Institute—an organization that unites researchers across multiple disciplines in an effort to address medical challenges around the world. He is an active participant in The Cancer Genome Atlas (TCGA)—a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), which are both part of the National Institutes of Health (NIH). In this role, Dr. Kwiatkowski is working on research projects relative to mesothelioma, bladder cancer, kidney chromophobe cancer, and adenocarcinoma and squamous cell carcinoma of the lung, among others.
A select listing of Dr. Kwiatkowski’s published articles:
Dana-Farber Cancer Institute Physician Profile-Research Tab
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Dana-Farber/Harvard Cancer Center